1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. RELMADA THERAPEUTICS INC
Relmada Therapeutics Inc
XNAS: RLMD
7.41 -0.23 (-3.01%)
731.9K
XNAS Volume

XNAS 04 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Relmada Therapeutics Inc is on 12 May 2026 for the purpose of Relmada Therapeutics Inc First Quarter Earnings Results for 2026 See details

Relmada Therapeutics Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents